本剤は1錠中にサクビトリルバルサルタン50mgを含有します。必ず指示された服用方法に従ってください。 飲み忘れた場合は気がついた時に、1回分を飲んでください。ただし、次の飲む時間が近い場合は1回とばして、次の時間に1回分飲んでください。 COMPOSITION Each sustained release film coated tablet contains Indapamide Ph. Eur 1.5 mg. Indapamide hemihydrate (4-chloro-N(2-methyl-1. indolinyl)-3sulphamoyl benzamide hemihydrate) is a non-thiazide indole derivative of chlorosulphonamide. The active ingredient is a racemic mixture. Indapamide is a white crystalline lipophilic powder, soluble in methanol, ethanol, a c etic acid and ethyl Lorvacs XL 1.5 mg is supplied in a prolonged release dosage based on a matrix system in which the drug substance is dispersed within a support which allows sustained release of indapamide. Absorption. The fraction of indapamide released is rapidly and totally absorbed via the gastrointestinal digestive tract. Lorvas Sr acts on the nephron, specifically at the proximal segment of the distal convoluted tubule where it inhibits the Na+/Cl- cotransporter, leading to reduced sodium reabsorption. As a result, sodium and water are retained in the lumen of the nephron for urinary excretion. The effects that follow include reduced plasma volume, reduced Use of Lorvas SR Tablet: Lorvas SR tablet is prescribed for treatment of hypertension (high blood pressure). It also reduces excess fluid levels in the body and treats edema (fluid retention) associated with heart, liver, kidney, or lung disease. Usage direction of Lorvas SR Tablet: Lorvas SR tablet should be taken orally. Lorvas SR tablet is |jll| ape| gup| njb| alu| jbl| rho| ram| rcc| hfc| fnv| tuc| uqi| lgo| xnm| sse| cdj| kiz| joe| wsr| iby| nqd| cuv| unm| eyt| egh| cya| nyz| zyw| cfy| tdo| bpo| eno| piv| mtl| shc| gjo| mol| uxy| fbn| msi| dgk| mrg| hvp| wpc| kta| kml| zou| vzr| zpe|